-
-
-
-
-
-
-
Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026
-
-
-
-
-
-
-
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
-
-
-
-
-
-
-
Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy
-
-
-
-
-
-
-
Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Climb Bio (CLYM) Appoints Perrin Wilson as Chief Business Officer
-
-
-
-
-
-
-
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
-
1,199,226 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


